The bioavailability and tissue affinity of BPC-157 varies by delivery method. Oral administration is notably stable against gastric acid breakdown and has shown pronounced benefits for gastrointestinal mucosa and gut microbiome balance. Subcutaneous administration provides rapid systemic distribution, often favored in tendon and musculoskeletal recovery studies.